THE Therapeutic Goods Administration has ordered the withdrawal of advertising by a company called Evolution Supplements, following a Dec complaint about the products which contain Schedule 4 substances including Selective Androgen Receptor Modulators.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jan 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jan 19
